Patents Assigned to WAVESENSE, INC.
  • Patent number: 10927366
    Abstract: Systems and methods for detecting and sequestering target analytes in a fluid sample. The system comprises a bulk specimen reservoir for receiving a liquid sample, along with paramagnetic materials operative to selectively bind to the target analyte of interest. A vertex is interconnected with the bulk specimen reservoir to define a specimen chamber assembly to which a magnetic chamber is deployed about the vertex portion thereof and operative to sequester the magnetic particles, as well as any analyte of interest bound thereto, within the interior of the vertex. Once sufficient time is allowed for mixing and allowing the magnetic capsule to sufficiently retain the magnetic particles within the vertex, the vertex is disconnected from the specimen reservoir and the paramagnetic materials retained therein analyzed to determine the presence of the analyte of interest.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: February 23, 2021
    Assignee: WAVESENSE, INC.
    Inventor: Christopher Feistel
  • Patent number: 10585101
    Abstract: Disclosed are methods to induce dislodgement of target prostatic cells from the prostate organ, collecting said cells, and subsequently examining the cell population. Such methods comprise the administration of an agent that facilitates the dislodgement of the target cells from within the prostate, which then migrate into the urethra. Exemplary agents include 5 alpha-reductase inhibitors. The cells induced to pass into the urethra are then collected non-invasively, such as through urine or semen samples. Such collection is further strategically calculated relative the administration of the agent so as to maximize the sample collection of the target cells of interest.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: March 10, 2020
    Assignee: WAVESENSE, INC.
    Inventor: Christopher Feistel
  • Patent number: 10329554
    Abstract: Systems and methods for detecting and sequestering target analytes in a fluid sample. The system comprises a bulk specimen reservoir for receiving a liquid sample, along with paramagnetic materials operative to selectively bind to the target analyte of interest. A vertex is interconnected with the bulk specimen reservoir to define a specimen chamber assembly to which a magnetic chamber is deployed about the vertex portion thereof and operative to sequester the magnetic particles, as well as any analyte of interest bound thereto, within the interior of the vertex. Once sufficient time is allowed for mixing and allowing the magnetic capsule to sufficiently retain the magnetic particles within the vertex, the vertex is disconnected from the specimen reservoir and the paramagnetic materials retained therein analyzed to determine the presence of the analyte of interest.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: June 25, 2019
    Assignee: WAVESENSE, INC.
    Inventor: Christopher Feistel
  • Publication number: 20180127741
    Abstract: Systems and methods for detecting and sequestering target analytes in a fluid sample. The system comprises a bulk specimen reservoir for receiving a liquid sample, along with paramagnetic materials operative to selectively bind to the target analyte of interest. A vertex is interconnected with the bulk specimen reservoir to define a specimen chamber assembly to which a magnetic chamber is deployed about the vertex portion thereof and operative to sequester the magnetic particles, as well as any analyte of interest bound thereto, within the interior of the vertex. Once sufficient time is allowed for mixing and allowing the magnetic capsule to sufficiently retain the magnetic particles within the vertex, the vertex is disconnected from the specimen reservoir and the paramagnetic materials retained therein analyzed to determine the presence of the analyte of interest.
    Type: Application
    Filed: November 7, 2016
    Publication date: May 10, 2018
    Applicant: WAVESENSE, INC.
    Inventor: CHRISTOPHER FEISTEL
  • Publication number: 20170261510
    Abstract: Disclosed are methods to induce dislodgement of target prostatic cells from the prostate organ, collecting said cells, and subsequently examining the cell population. Such methods comprise the administration of an agent that facilitates the dislodgement of the target cells from within the prostate, which then migrate into the urethra. Exemplary agents include 5 alpha-reductase inhibitors. The cells induced to pass into the urethra are then collected non-invasively, such as through urine or semen samples. Such collection is further strategically calculated relative the administration of the agent so as to maximize the sample collection of the target cells of interest.
    Type: Application
    Filed: March 10, 2016
    Publication date: September 14, 2017
    Applicant: WAVESENSE, INC.
    Inventor: CHRISTOPHER FEISTEL
  • Patent number: D886320
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: June 2, 2020
    Assignee: WAVESENSE, INC.
    Inventors: Timothy M. Bruemmer, Bruce D. Irvine, Christopher Feistel
  • Patent number: D890362
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: July 14, 2020
    Assignee: WAVESENSE, INC.
    Inventors: Timothy M. Bruemmer, Bruce D. Irvine, Christopher Feistel, Pawel Juraszek